Skip to main content

Advertisement

Log in

Ryanodine Receptor Expression Correlates with Tumor Grade in Breast Cancer

  • Original Paper
  • Published:
Pathology & Oncology Research

Abstract

Ryanodine receptors (RyRs) have been previously implicated in the proliferation of human T-lymphocytes and melanocytes as well as in the motility of astrocytes. We have examined RyR expression in 57 ductal, human breast cancer specimens, by immunohistochemistry. Moderate to high RyR immunostaining was found in 47 (82%) of the specimens. There was a direct correlation between RyR levels and tumor grade (r = 0.48, p = 0.0002). We have also examined the effect of the RyR agonist 4-chloro-m-cresol on the in-vitro growth of two human breast cancer cell lines, MCF-7 and MDA-MB-231. Treatment with 4-chloro-m-cresol inhibited the growth of both breast cancer cell lines, in a dose-dependent manner, with half-maximal inhibition observed at 30 to 50 μg/mL (210–351 μM). Our data suggest that RyR could serve as prognostic indicator and/or as a target for breast cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

Ca2+:

calcium ion

RyR:

ryanodine receptor

Bca:

breast cancer

PBS:

phosphate buffered saline

RT:

room temperature

HRP:

horseradish peroxidase

DAB:

3,3′-diaminobenzidine

L:

Leibovitz’s

ER+ve:

estrogen receptor alpha positive

ER−ve:

estrogen receptor alpha negative

References

  1. Bootman MD, Lipp P, Berridge MJ (2001) The organization and functions of local Ca(2+) signals. J Cell Sci 114:2213–2222

    PubMed  CAS  Google Scholar 

  2. Mackrill JJ (1999) Protein–protein interactions in intracellular Ca2+-release channel function. Biochem J 337:345–361

    Article  PubMed  CAS  Google Scholar 

  3. Fill M, Copello JA (2002) Ryanodine receptor calcium release channels. Physiol Rev 82:893–922

    PubMed  CAS  Google Scholar 

  4. Hakamata Y, Nishimura S, Nakai J et al (1994) Involvement of the brain type of ryanodine receptor in T-cell proliferation. FEBS Lett 352:206–210

    Article  PubMed  CAS  Google Scholar 

  5. Kang HY, Kim NS, Lee CO et al (2000) Expression and function of ryanodine receptors in human melanocytes. J Cell Physiol 185:200–206

    Article  PubMed  CAS  Google Scholar 

  6. Matyash M, Matyash V, Nolte C et al (2002) Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J 16:84–86

    PubMed  CAS  Google Scholar 

  7. Mariot P, Prevarskaya N, Roudbaraki M et al (2000) Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. Prostate 43:205–214

    Article  PubMed  CAS  Google Scholar 

  8. Timar J, Kasler M, Katai J et al (2006) Developments in cancer management by innovative genomics: 2006 report of the National Cancer Consortium. Hungarian Oncology 50:349–359

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported, in part, by South Carolina (SC) INBRE (IDeA Network of Biomedical Research Excellence) Grant Number RR16461 and the SC LIFE Undergraduate Research Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naseema Hoosein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdul, M., Ramlal, S. & Hoosein, N. Ryanodine Receptor Expression Correlates with Tumor Grade in Breast Cancer. Pathol. Oncol. Res. 14, 157–160 (2008). https://doi.org/10.1007/s12253-008-9045-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-008-9045-9

Keywords

Navigation